ERIKA NICHOLS: Open Payments
NPI 1922698273 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 17 payments from 10 companies in 2025. Trend: 2023 $57 · 2024 $69 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $201 |
| CVRx, Inc. | 1 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Becton, Dickinson and Company | 1 | $26 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Ozempic, Barostim Neo System, LEQVIO, AMVUTTRA, Venclose Maven Catheter, Attruby, EDARBI, FARXIGA.
Industry payments across FL — which companies pay providers there.
